Mary Skafidas
Senior Vice President, Investor Relations and Communications
Replay available
AptarGroup, Inc. (ATR) Q2 2026 Earnings Call
AptarGroup, Inc. (NYSE: ATR) Q2 2026 earnings conference call, held 2026-07-31. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Matt Roberts
Analyst, Raymond James & Associates
George Staffos
Analyst, Bank of America Securities
Stephan Tanda
President and Chief Executive Officer
Vanessa Kanu
Executive Vice President and Chief Financial Officer
Gael Touya
CEO designate and President of Aptar Pharma
Ganshum Zhoubi
Analyst, Robert W. Baird & Co.
Matt LaRue
Analyst, William Blair & Company
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Aptargroup, Inc..
Replay transcript excerpt
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a041e6-0918-7e20-9963-83fd8683a0ba Created: 2026-08-27T06:26:32.106Z Duration: 3379.3044 Channels: 1 00:00:00.000 -- 00:00:02.959 Ladies and gentlemen, thank you for standing by. 00:00:03.280 -- 00:00:04.799 Welcome to Aptar's 00:00:04.799 -- 00:00:08.719 twenty twenty six Second Quarter Results Conference Call. 00:00:08.960 -- 00:00:11.759 At this time, all participants are in a 00:00:11.759 -- 00:00:14.615 listen only mode. Later, we will conduct a 00:00:14.615 -- 00:00:16.295 question and answer session. 00:00:16.935 -- 00:00:19.015 Introducing today's conference 00:00:19.175 -- 00:00:22.215 call is Mrs. Mary Scafitis, 00:00:22.695 -- 00:00:26.935 Senior Vice President, Investor Relations and Communications. 00:00:27.175 -- 00:00:27.975 Please go ahead. 00:00:32.030 -- 00:00:34.430 Hello, everyone, and thanks for being with us 00:00:34.430 -- 00:00:37.870 today. Joining me on today's call are Stephane 00:00:37.870 -- 00:00:40.430 Tanda, our President and CEO 00:00:40.989 -- 00:00:42.270 Vanessa Canoe, 00:00:42.350 -- 00:00:44.510 Executive Vice President and CFO 00:00:45.325 -- 00:00:47.004 and Gayel Tuya, 00:00:47.085 -- 00:00:48.844 our CEO designate 00:00:48.925 -- 00:00:51.165 and President of Aptar Pharma. 00:00:51.965 -- 00:00:54.445 Our press release and accompanying slide deck have 00:00:54.445 -- 00:00:56.524 been posted on our website under the Investor 00:00:56.524 -- 00:00:57.324 Relations page. 00:00:58.040 -- 00:01:00.360 During this call, we will be discussing certain 00:01:00.360 -- 00:01:02.120 non GAAP financial measures. 00:01:02.520 -- 00:01:05.160 These measures are reconciled to the most directly 00:01:05.160 -- 00:01:07.240 comparable GAAP financial measure, 00:01:07.560 -- 00:01:0...